Sanofi SA Will Acquire Principia Biopharma Inc For $ 3.7 Billion
France-based pharmaceutical company Sanofi SA announced that it will acquire the biotech company Principia Biopharma Inc. for approximately $ 3.7 billion.
Sanofi SA Will Acquire Principia Biopharma Inc For $ 3.7 Billion
France-based pharmaceutical company Sanofi SA announced that it will acquire the US California-based biotech company Principia Biopharma Inc for approximately $ 3.7 billion.
According to the statement made by Sanofi, the acquisition of the US-based Principia will positively contribute to the company's research and development efforts against allergic and congenital immunity related diseases.
Sanofi CEO Paul Hudson stressed that the company is committed to continuing its efforts to provide the most promising medicines that will meet the essential needs of patients.Following the announcement of the acquisition progress, Sanofi shares started to rise, although its performance was 4.0 percent below the same period last year.